Chikungunya virus of Asian and Central/East African genotypes in Malaysia

I-Ching Sam1, Yoke Fun Chan, Shie Yien Chan

  • 1Tropical Infectious Diseases Research and Education Centre, Department of Medical Microbiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia. jicsam@um.edu.my

Abstract

Insights

The 2008 Malaysian Chikungunya virus (CHIKV) outbreak was caused by the Central/East African genotype, featuring the A226V mutation. This mutation likely explains the extensive spread, and cross-neutralization suggests potential for vaccines.

Area of Science:

  • Virology
  • Epidemiology
  • Immunology

Background:

  • Chikungunya virus (CHIKV) outbreaks, particularly those of the Central/East African genotype, have occurred globally.
  • Malaysia experienced limited CHIKV outbreaks in 1998 and 2006, involving Asian and Central/East African genotypes.
  • An unprecedented nationwide CHIKV outbreak began in Malaysia in April 2008.

Purpose of the Study:

  • To investigate the molecular epidemiology of the 2008 Malaysian CHIKV outbreak.
  • To assess the cross-neutralization activity of patient serum against different CHIKV genotypes.

Main Methods:

  • Phylogenetic analysis of the E1 gene from 83 patient samples (837bp).
  • PCR, virus isolation, and IgM testing were performed on patient serum.
  • Cross-neutralization assays using convalescent serum from the 2008 and 2006 outbreaks.

Main Results:

  • CHIKV was confirmed in 34 (41.0%) patients.
  • The 2008 outbreak strain possessed the A226V mutation in the E1 protein and clustered with Central/East African isolates.
  • Serum demonstrated cross-neutralization activity against both Central/East African and Asian genotypes (titers 40-1280).

Conclusions:

  • The 2008 Malaysian CHIKV outbreak was driven by the Central/East African genotype.
  • The A226V mutation likely enhanced CHIKV transmissibility by Aedes albopictus, contributing to widespread rural transmission.
  • Observed cross-neutralization suggests potential for vaccine development to mitigate future CHIKV outbreaks.